Improving operative safety for cirrhotic liver resection

British Journal of Surgery

Volumn 88, Issue 2, 2001, Pages 210-215

  Wu, C C ^a   Yeh, D C ^a   Lin, M C ^a   Liu, T J ^a   P'Eng, F K ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRANCHED CHAIN AMINO ACID; CIMETIDINE; DOPAMINE;

ADULT; AGE; AGED; ARTICLE; BLOOD TRANSFUSION; FEMALE; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OPERATION DURATION; PATIENT MONITORING; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTHROMBIN TIME; SAFETY; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; HUMANS; LENGTH OF STAY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SAFETY; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME;

EID: 0035136634     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2001.01653.x     Document Type: Article

References (27)

1. Retrospective analysis of type of hepatic resection for hepatocellular carcinoma
2. Liver resection for colorectal metastases
3. Role of hepatic resection in surgery for bilateral intrahepatic stones
4. Impact of hospital volume on operative mortality for major cancer surgery
5. Liver resection in cirrhosis of the liver
6. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis
7. Surgery for small liver cancers
8. Criteria for safe hepatic resection
9. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: Is there a way? A prospective analysis of our approach
10. A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease
11. Hepatectomy for hepatocellular carcinoma toward zero hospital deaths
12. Hepatic resection of hepatocellular carcinoma in cirrhotic livers: Is it unjustified in impaired liver function?
13. Effects and limitations of prolonged intermittent ischaemia for hepatic resection of the cirrhotic liver
14. Prediction and limitation of hepatic tumor resection without blood transfusion in cirrhotic patients
15. Transection of the oesophagus for bleeding oesophageal varices
16. The role of anesthesia in surgical mortality
17. Concomitant splenectomy for hypersplenic thombocytopenia in hepatic resection for hepatocellular carcinoma
18. Endoscopic and imaging assessment of esophageal varices
19. Clinical practice guideline: Incentive spirometry
20. Prospective randomized trial of systemic antibiotics in patients undergoing liver resection
21. Total vascular exclusion of the liver during hepatic surgery. Selective use, extensive use, or abuse?
22. Effect of hyperdynamic circulatory support on hepatic hemodynamics, oxygen supply and demand after massive hepatectomy
23. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma
24. Surgical treatment for recurrent hepatocellular carcinoma with tumor thrombi in right atrium: Using cardiopulmonary bypass and deep hypothermic circulatory arrest
25. Fibrin glue effectiveness and tolerance after liver resection: A randomized trial
26. Peptic ulceration in patients with chronic liver disease